A meta-analysis of the prognostic role of NLR in breast cancer suggested that high NLR was associated with adverse OS and DFS in breast cancer patients and had a greater impact on disease-specific outcomes in ER- and HER2-negative disease [25]. This evidence concerns the gene ERBB2 and breast carcinoma.